Article

Fungus-Infected Steroid Injections Now Include Joints

The outbreak of contaminated steroid injections has now grown to include two patients injected into their ankles, reportedly causing septic arthritis.

In an ongoing investigation of an outbreak of fungus-contaminated steroid injections, the Centers for Disease Control and Prevention (CDC) is now alerting physicians to 2 patients who appear to have received contaminated  injections into joints rather than into their spinal columns. At a CDC press conference, according to a report in Rheumatology News, a medical epidemiologist revealed that the two non-spinal cases were ankle injections, predating the current outbreak but traced back, like the epidural cases, to the New England Compounding Center in Massachusetts.

Both patients who received contaminated injections in their ankles reportedly developed septic arthritis as a result.

The CDC has identified the fungus Exserohilum rostratum as the primary contaminant in this outbreak, although one sample was positive for Aspergillus fumigatus and another for Cladosporium. The latest physician guidance document from CDC gives detailed instructions for identifying and managing suspected cases of contamination.

CDC reports that 225 experts have been working around the clock in response to the outbreak, collaborating with state health departments to contact the 14,000-odd patients who may have been exposed. Updated information is available at the CDC's blog on the outbreak, and the agency also maintains a rapid response presence on Twitter at hashtag #CDC247.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.